Risk factors for the rising rates of primary liver cancer in the United States - PubMed (original) (raw)
Risk factors for the rising rates of primary liver cancer in the United States
H B El-Serag et al. Arch Intern Med. 2000.
Abstract
Background: A recent increase in the incidence of hepatocellular carcinoma was reported in the United States. The cause of this witnessed rise remains unknown.
Methods: We examined the temporal changes in both age-specific and age-standardized hospitalization rates of primary liver cancer associated with hepatitis C, hepatitis B, and alcoholic cirrhosis in the Department of Veterans Affairs Medical Center's Patient Treatment File.
Results: A total of 1605 patients were diagnosed with primary liver cancer between 1993 and 1998. The overall age-adjusted proportional hospitalization rate for primary liver cancer increased from 36.4 per 100,000 (95% confidence interval [CI], 34.0-38.9) between 1993 and 1995 to 47.5 per 100,000 (95% CI, 44.6-50.1) between 1996 and 1998. There was a 3-fold increase in the age-adjusted rates for primary liver cancer associated with hepatitis C virus, from 2.3 per 100,000 (95% CI, 1. 8-3.0) between 1993 and 1995 to 7.0 per 100,000 (95% CI, 5.9-8.1) between 1996 and 1998. Concomitant with this rise, the age-specific rates for primary liver cancer associated with hepatitis C also shifted toward younger patients. During the same periods, the age-adjusted rates for primary liver cancer associated with either hepatitis B virus (2.2 vs 3.1 per 100,000) or alcoholic cirrhosis (8. 4 vs 9.1 per 100,000) remained stable. The rates for primary liver cancer without risk factors also remained without a statistically significant change, from 17.5 (95% CI, 15.8-19.1) between 1993 and 1995 to 19.0 per 100,000 (95% CI, 17.3-20.7) between 1996 and 1998.
Conclusions: Hepatitis C virus infection accounts for most of the increase in the number of cases of primary liver cancer among US veterans. The rates of primary liver cancer associated with alcoholic cirrhosis and hepatitis B virus infection have remained stable. Arch Intern Med. 2000;160:3227-3230.
Similar articles
- The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
El-Serag HB, Richardson PA, Everhart JE. El-Serag HB, et al. Am J Gastroenterol. 2001 Aug;96(8):2462-7. doi: 10.1111/j.1572-0241.2001.04054.x. Am J Gastroenterol. 2001. PMID: 11513191 - Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.
Kramer JR, El-Serag HB, Taylor TJ, White DL, Asch SM, Frayne SM, Cao Y, Smith DL, Kanwal F. Kramer JR, et al. J Viral Hepat. 2017 Nov;24(11):955-965. doi: 10.1111/jvh.12728. Epub 2017 Aug 16. J Viral Hepat. 2017. PMID: 28815822 Free PMC article. - Epidemiology of hepatocellular carcinoma.
el-Serag HB. el-Serag HB. Clin Liver Dis. 2001 Feb;5(1):87-107, vi. doi: 10.1016/s1089-3261(05)70155-0. Clin Liver Dis. 2001. PMID: 11218921 Review. - Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R. Chiaramonte M, et al. Cancer. 1999 May 15;85(10):2132-7. Cancer. 1999. PMID: 10326690 - Hepatocellular carcinoma: status in the era of liver transplantation.
Singhal A, Jabbour N. Singhal A, et al. J Okla State Med Assoc. 2009 Dec;102(12):355-61. J Okla State Med Assoc. 2009. PMID: 20131731 Review. No abstract available.
Cited by
- Complex Multi-site Stereotactic Body Re-irradiation With CT-Guided Online Adaptive Radiotherapy.
Sievert D, D'Souza A, Zhao X, Prusator MT, Mazur T, Kim H, Hobbis D. Sievert D, et al. Cureus. 2024 Sep 3;16(9):e68559. doi: 10.7759/cureus.68559. eCollection 2024 Sep. Cureus. 2024. PMID: 39364455 Free PMC article. - Insights in Molecular Therapies for Hepatocellular Carcinoma.
Heumann P, Albert A, Gülow K, Tümen D, Müller M, Kandulski A. Heumann P, et al. Cancers (Basel). 2024 May 10;16(10):1831. doi: 10.3390/cancers16101831. Cancers (Basel). 2024. PMID: 38791911 Free PMC article. Review. - Trans-2-nonadecyl-4-(hydroxymethyl)-1,3-dioxolane (TNHD) purified from freshwater clams markedly alleviates dimethylnitrosamine-induced hepatic fibrosis.
Kuo YR, Tsai CY, Lin WS, Chang CI, Lai CS, Pan MH. Kuo YR, et al. J Food Drug Anal. 2024 Mar 15;32(1):1-20. doi: 10.38212/2224-6614.3491. J Food Drug Anal. 2024. PMID: 38526593 Free PMC article. - Hepatocellular Carcinoma Incidence and Mortality in the USA by Sex, Age, and Race: A Nationwide Analysis of Two Decades.
Abboud Y, Ismail M, Khan H, Medina-Morales E, Alsakarneh S, Jaber F, Pyrsopoulos NT. Abboud Y, et al. J Clin Transl Hepatol. 2024 Feb 28;12(2):172-181. doi: 10.14218/JCTH.2023.00356. Epub 2024 Jan 2. J Clin Transl Hepatol. 2024. PMID: 38343612 Free PMC article. - Assessing Physicians' Recommendations for Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Testing Among Minority Populations in Greater Philadelphia and New York City.
Begum TF, Patil VS, Zhu L, Yeh MC, González E, Fraser MA, Lu W, Zhu S, Rubio-Torio N, Ma GX, Tan Y. Begum TF, et al. J Community Health. 2024 Aug;49(4):588-597. doi: 10.1007/s10900-023-01316-3. Epub 2024 Jan 29. J Community Health. 2024. PMID: 38286964
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical